Genetic Medicine Advances Shadowed by Regulatory Issues

Genetic Medicine Advances Shadowed by Regulatory Issues

Gene-sequencing breakthroughs, spawning fast-growing, multibillion-dollar markets for drugs, software and medical tests, are also creating thorny issues over how to regulate commercial use of the human genetic code. Illustration: Rich Clement/Bloomberg